BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22790261)

  • 1. Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.
    Chao YH; Wu KH; Lu JJ; Shih MC; Peng CT; Chang CW
    Blood Transfus; 2013 Jan; 11(1):71-4. PubMed ID: 22790261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia.
    Thompson AA; Cunningham MJ; Singer ST; Neufeld EJ; Vichinsky E; Yamashita R; Giardina P; Kim HY; Trachtenberg F; Kwiatkowski JL;
    Br J Haematol; 2011 Apr; 153(1):121-8. PubMed ID: 21323889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
    Cheng CK; Lee CK; Lin CK
    Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi.
    Mo Z; Li H; Huang L; Jiao W
    Transfus Med; 2015 Oct; 25(5):313-9. PubMed ID: 26135712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent β-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Sarihi R; Amirizadeh N; Oodi A; Azarkeivan A
    Hemoglobin; 2020 Jan; 44(1):31-36. PubMed ID: 32400249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.
    Wang LY; Liang DC; Liu HC; Chang FC; Wang CL; Chan YS; Lin M
    Transfus Med; 2006 Jun; 16(3):200-3. PubMed ID: 16764599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel.
    Pazgal I; Yahalom V; Shalev B; Raanani P; Stark P
    Ann Hematol; 2020 Dec; 99(12):2731-2736. PubMed ID: 32488601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
    El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
    Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.
    Guirat-Dhouib N; Mezri M; Hmida H; Mellouli F; Kaabi H; Ouderni M; Zouari B; Hmida S; Bejaoui M
    Transfus Apher Sci; 2011 Oct; 45(2):199-202. PubMed ID: 21889408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe hemolysis related to an association of erythrocyte allo- and autoantibodies in a thalassemia patients].
    Mizon P; Cossement C; Mannessier L; Caulier MT; Rose C; Goudemand J
    Transfus Clin Biol; 1996; 3(4):257-61. PubMed ID: 8983518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
    Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related red blood cell alloantibodies: induction and consequences.
    Tormey CA; Hendrickson JE
    Blood; 2019 Apr; 133(17):1821-1830. PubMed ID: 30808636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.